15360676961
首页 > 新闻中心 > 研发生产甲磺酸罗哌卡因 CAS: 854056-07-8原料供应发货实验室定制现货直销
新闻中心
研发生产甲磺酸罗哌卡因 CAS: 854056-07-8原料供应发货实验室定制现货直销
发布时间:2023-10-16        浏览次数:13        返回列表
研发生产甲磺酸罗哌卡因 CAS: 854056-07-8原料供应发货实验室定制现货直销
中文名甲磺酸罗哌卡因
英文名Ropivacaine mesylate
别名甲磺酸罗哌卡因
罗哌卡因甲磺酸盐
甲磺酸罗哌卡因中间体
S-罗哌卡因甲磺酸盐
甲磺酸罗哌卡因
N-(2,6-二甲基苯基)-1-丙基哌啶-2-甲酰胺甲磺酸盐
N-(2,6-二甲基苯基)-1-正丙基哌啶-2-甲酰胺甲磺酸盐
(S)-N-(2,6-二甲基苯基)-1-丙基-2-哌啶酰胺甲磺酸盐
S-(-)-N-(2,6-二甲基苯基)-1-丙基-2-哌啶甲酰胺甲磺酸盐
英文别名ROPIVACAINE MESYLATE
Ropivacaine mesylate
S-Ropivacaine mesylate
(S)-Ropivacaine Mesilate
Ropivacaine Mesylate API
Ropivacaine Mesylate Injection
TIANFUCHEM----Ropivacaine mesylate in stock
(S)-N-(2,6-Dimethylphenyl)-1-propylpiperidine-2-carboxamidemethanesulfonate
(2S)-N-(2,6-Dimethylphenyl)-1-propyl-2-piperidinecarboxamide monomethanesulfonate
Ropivacaine mesylate (2S)-N-(2,6-Dimethylphenyl)-1-propyl-2-piperidinecarboxamide monomethanesulfonate
CAS
EINECS
化学式C18H30N2O4S
分子量370.51
InChIInChI=1/C17H26N2O.CH4O3S/c-5-10-15(19)17(20)18-16-13(2)8-7-9-14(16)3;1-5(2,3)4/h7-9,15H,4-6,10-12H2,1-3H3,(H,18,20);1H3,(H,2,3,4)/t15-;/m0./s1
体内研究Epidural administration of Ropivacaine mesylate effectively blocks neuropathic pain (both mechanical allodynia and heat hyperalgesia) without induction of analgesic tolerance and significantly delays the development of neuropathic pain produced by peripheral nerve injury. Ropivacaine mesylate inhibits pressure-induced increases in filtration coefficient (Kf) without affecting pulmonary artery pressure (Ppa), pulmonary capillary pressures (Ppc), and zonal characteristics (ZC). Ropivacaine mesylate prevents pressure-induced lung edema and associated hyperpermeability as evidence by maintaining PaO2, lung wet-to-dry ratio and plasma volume in levels similar to sham rats. Ropivacaine mesylate inhibits pressure-induced NO production as evidenced by decreased lung nitro-tyrosine content when compared to hypertensive lungs. Animal Model: Adult Sprague-Dawley rats (300-400g) Dosage: 1 μM Administration: Infusion (added to the perfusate reservoir) Result: Attenuated pressure-dependent increases in filtration coefficient (K f ).


核心提示:医药中间体
刚发布的文章
联系方式
  • 地址:江苏省南京市雨花台区安德门大街57号
  • 电话:15360676961
  • 手机:15360676961
  • 传真:南京辰瑞晟生物医药科技有限公司
  • 联系人:诸璐
新闻分类
最新发布
企业新闻